TY - JOUR
T1 - WHO informal consultation on the application of molecular methods to assure the quality, safety and efficacy of vaccines, Geneva, Switzerland, 7-8 April 2005
AU - Shin, Jinho
AU - Wood, David
AU - Robertson, James
AU - Minor, Philip
AU - Peden, Keith
AU - WHO Informal Consultation Group
A2 - Fischer, Thea Kølsen
PY - 2007/3
Y1 - 2007/3
N2 - In April 2005, the World Health Organization convened an informal consultation on molecular methods to assure the quality, safety and efficacy of vaccines. The consultation was attended by experts from national regulatory authorities, vaccine industry and academia. Crosscutting issues on the application of molecular methods for a number of vaccines that are currently in use or under development were presented, and specific methods for further collaborative studies were discussed and identified. The main points of recommendation from meeting participants were fourfold: (i) that molecular methods should be encouraged; (ii) that collaborative studies are needed for many methods/applications; (iii) that basic science should be promoted; and (iv) that investment for training, equipment and facilities should be encouraged.
AB - In April 2005, the World Health Organization convened an informal consultation on molecular methods to assure the quality, safety and efficacy of vaccines. The consultation was attended by experts from national regulatory authorities, vaccine industry and academia. Crosscutting issues on the application of molecular methods for a number of vaccines that are currently in use or under development were presented, and specific methods for further collaborative studies were discussed and identified. The main points of recommendation from meeting participants were fourfold: (i) that molecular methods should be encouraged; (ii) that collaborative studies are needed for many methods/applications; (iii) that basic science should be promoted; and (iv) that investment for training, equipment and facilities should be encouraged.
KW - BCG Vaccine/standards
KW - Humans
KW - Molecular Probe Techniques
KW - Oligonucleotide Array Sequence Analysis
KW - Poliovirus Vaccines/standards
KW - Quality Control
KW - Safety
KW - Switzerland
KW - Vaccines/adverse effects
KW - World Health Organization
U2 - 10.1016/j.biologicals.2005.12.005
DO - 10.1016/j.biologicals.2005.12.005
M3 - Journal article
C2 - 17321940
SN - 1045-1056
VL - 35
SP - 63
EP - 71
JO - Biologicals : journal of the International Association of Biological Standardization
JF - Biologicals : journal of the International Association of Biological Standardization
IS - 1
ER -